explore -WSS

explore

author：leisure time 2025-09-27 12:54:58 - browse：6316

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Eli Lilly expects to double planned employment in Boston center

knowledge

WSS

Australia’s approach to dialysis celebrates life

STAT Summit: How a Chicago ER doctor tackles gun violence

Psilocybin's anti

Winners, losers from Medicare’s list of drugs subject to price talks

Impact of Dobbs ruling felt at reproductive medicine meeting

Apellis safety probe of eye disease drug centers on injection needle

Wikipedia

explore

leisure time

How to save PrEP access — and even expand it

Eli Lilly expects to double planned employment in Boston center

Duchenne breakthrough therapy leaves behind pioneering families

Radiation, mainstay of cancer treatment, begins a fade

New air purifier tech could be key to improving indoor air quality

Researchers explore possible ties between long Covid, menopause

DIEP, the 'gold standard' of breast reconstruction, is under threat

As pharma fights Medicare drug negotiation, hospitals, docs silent

Bright Health sells Medicare Advantage business to Molina

What do new weight loss drugs mean for bariatric surgery?

explore

How to make Best Hospitals ratings actually useful for patients

NYU Langone launches private ChatGPT for its health care data

Hospital price transparency does save money, advocate argues

UnitedHealth’s board chair also owns a personal investment firm

What AAP's gender

How a symptom of dementia informs our understanding of creativity

focus

explore

knowledge

knowledge